Popular Articles

Physician Shortage Could Hinder Health Reform
The number of new primary care doctors each year has fallen nearly 50 percent since 1997, the Dallas Morning News reports, leaving a shortage that could hinder Congress"s ambition to reform health care and cover millions of uninsured Americans. One cause of the shortage is that primary care doctors earn less - the average pediatrician makes $171,000 compared with $480,000 for orthopedic surgeons, according to one study - but must pay back medical school debts similar to those drawn by their higher-paid colleagues. As a result the higher paid specialists outnumber primary care physicians 2 to 1 (Roberson, 7/6).
drugs without prescription
ZyGEM Releases Data Confirming Its PrepGEM(R) Bacteria Kit Is A Simple, Universal Method For Extracting DNA From Different Bacteria Species
ZyGEM Corp. Ltd., a provider of innovative enzyme-based products for DNA extraction and other life sciences applications, today announced the availability of a new application note documenting that its prepGEM(R) Bacteria DNA extraction kit is capable of producing high quality, ready-to-analyze DNA from a broad range of bacterial species, including mixed or unknown sample types. This addresses an important unmet need --current DNA extraction methods typically require the use of different enzymes for each type of bacteria tested. The prepGEM(R) Bacteria kit also uses a single closed-tube system that reduces extraction time and cost while protecting the sample from contamination and making the kit easily adaptable for automation.
News of the day
Chronic Pelvic Pain Syndromes: Clinical, Urodynamic, And Urothelial Observations
UroToday.com - Patients with pain can present with various symptom complexes that include interstitial cystitis, vulvodynia, irritable bowel syndrome, myofascial pain or various causes of dyspareunia but when carefully evaluated, the majority have very similar findings. No matter what their primary complaint might be over 70% of patients will have hypertonic pelvic floor dysfunction and/or pain as well as a component of at least one visceral pain syndrome such as interstitial cystitis (the most common), chronic pelvic pain or irritable bowel syndrome.
Health Insurance

New Once-daily Treatment For Type 2 Diabetes

A new treatment for Type 2 diabetes has hit the headlines today. Liraglutide (Victoza), a once-daily injectable treatment for Type 2 diabetes, is pharmaceutical company Novo Nordisk"s latest brain child. From the Glucoagon-like peptide-1 (GLP-1) family of drugs, it can be taken any time of day, irrespective of meals. It helps to control Type 2 diabetes by stimulating the release of insulin when blood glucose levels are too high. In addition, makers claim liraglutide aids weight loss by making you feel more full and delaying the rate at which your stomach empties. Studies have also shown that the drug can reduce blood pressure and improve the function of beta cells - the cells that produce insulin in the pancreas. Cathy Moulton, Care Advisor at leading health charity Diabetes UK, said: "Liraglutide widens the choice of treatments for people with Type 2 diabetes that not only offer improved blood glucose control but also aid weight loss. In addition, research has shown that this treatment has a positive effect on blood pressure levels. "Diabetes UK welcomes safe and effective treatments that give people with diabetes choice in how to best manage their condition. In addition to any prescribed medication, people with diabetes should eat a healthy balanced diet and do regular physical activity. Good diabetes management reduces the risk of developing serious complications including heart disease, stroke, kidney failure, blindness and amputation." Diabetes UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):